Ovarian Cancer, Primary Peritoneal Cancer
1 clinical trials · Condition
◉ Watch Ovarian Cancer, Primary Peritoneal Cancer
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) (NCT00635193) | AbbVie (prior sponsor, Abbott) | 2007-07-01 |
Track Ovarian Cancer, Primary Peritoneal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.